Work

Adipocyte Enhancer Binding Protein 1 (AEBP1) Inhibition as a Potential Anti-Fibrotic Therapy in Heart Failure.

Year: 2023

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-3390276/v1

Authors: Thirupura Sundari Shankar, Joseph Visker, Junedh Amrute, Georgiy Polishchuk, Ty Lunde, Jing Ling, Peter Ferrin, Rana Hamouche, Dominik Feigle, Dallen Calder, Frank Sachse, Christos Kyriakopoulos, Eleni Maneta, Eleni Tseliou, Sutip Navankasattusas, Craig Selzman, Thomas Seidel, Kory Lavine, Stavros Drakos

Institutions: University of Utah, Washington University in St. Louis, Friedrich-Alexander-Universität Erlangen-Nürnberg

Language: English

Topic: Cardiac Fibrosis and Remodeling

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, American Heart Association, National Institutes of Health

Awards: Adipocyte enhancer binding protein 1 (AEBP1) as a potential therapeutic target to combat cardiac fibrosis, G799929830, Elucidating ACLP-dependent signaling pathways in the adipose tissue stromal-vascular niche, Deconstructing the diet-induced remodeling of adipose tissue

OpenAlex ID: W4387700248

Cites: 42

Cited by: 1

Related to: 10